Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH)

NCT01462565 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension, Pulmonary

Interventions

DRUG: current marketed FLOLAN (epoprostenol sodium)
DRUG: new thermo stable formulation of epoprostenol sodium

Sponsor

GlaxoSmithKline